MedTrace Logo

Metabolic Response Evaluation of Low-sugar Snack Bars

NCT04653220 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-08-31

No results posted yet for this study

Summary

To determine the post-prandial metabolic response and biomarker response, following the consumption of newly developed low glycaemic index (GI) snack bars. The snack bars are formulated with different combinations and ratios of ingredients and food structures. The low sugar products maintaining glucose homeostasis and preventing metabolic problems may have commercial potential as a novel functional ingredient in a variety of fields, including nutrition, medicine, and agriculture.

Conditions

Interventions

OTHER

Control 1

25g glucose dissolve in 250ml of water

OTHER

Control 2

25g glucose dissolve in 250ml of water

OTHER

Standard Crokao

Standard Crokao containing 25g of available carbohydrate

OTHER

Low sugar variant 1

Low sugar variant 1 containing 25g of available carbohydrate

OTHER

Low sugar variant 2

Low sugar variant 2 containing 25g of available carbohydrate

OTHER

Low sugar variant 3

Low sugar variant 3 containing 25g of available carbohydrate

OTHER

Low sugar variant 4

Low sugar variant 4 containing 25g of available carbohydrate

OTHER

Low sugar variant 5

Low sugar variant 5 containing 25g of available carbohydrate

Sponsors & Collaborators

  • Singapore Institute of Food and Biotechnology Innovation

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-13
Primary Completion
2023-05-26
Completion
2023-05-26

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04653220 on ClinicalTrials.gov